Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study.

Olav DalgardOla WeilandGeir NorabergLars KarlsenLars HeggelundMartti FärkkilâUlla BalslevErika BelardAnne ØvrehusMette Skalshøi KjærHenrik KrarupBirgit Thorup RøgeSofie HallagerLone G MadsenAlex Lund LaursenMartin LaggingNina Weis

Published in: PloS one (2017)

We found that sofosbuvir based treatment in a real-life setting could offer SVR rates exceeding 90% in patients with HCV genotype 3 infection and advanced liver disease.

Keyphrases

hepatitis c virus
human immunodeficiency virus
antiretroviral therapy